Target intelligence / Profile preview

DNA-directed RNA polymerase II subunit M (POLR2M)

Target
POLR2M
Molecular classification
Transcription factor (subunit), Enzyme (subunit of a multi-subunit enzyme complex)
01

Overview

DNA-directed RNA polymerase II subunit M (POLR2M) is a metazoan-specific component of a specialized form of RNA polymerase II, termed Pol II(G), which is essential for eukaryotic messenger RNA transcription[1][3]. POLR2M, also known as Gdown1, is tightly and stoichiometrically associated with the RNA polymerase II complex, where it functions predominantly as a negative regulator of transcriptional activation in the absence of the Mediator complex[2][3][4][7][8]. Gdown1 binding occludes the interaction sites for crucial general transcription factors (TFIIF and TFIIB), thereby repressing transcription initiation by preventing preinitiation complex assembly[2]. This repressive action is specifically reversed by the Mediator complex, allowing regulated gene expression in response to signaling[2][4]. While POLR2M/Gdown1 is ubiquitously expressed and implicated in early developmental gene silencing, it is not independently targeted by therapeutic drugs and is not currently classified as a biomarker or direct disease gene[2][3][7]. Its key role lies in the basal mechanisms of RNA polymerase II transcriptional regulation.

Other names
DNA-directed RNA polymerase II subunit GRINL1AGdownGdown1GRINL1AGlutamate receptor-like protein 1AGCOM1GRINL1A downstream protein Gdown4glutamate receptor, ionotropic, N-methyl D-aspartate-like 1Apolymerase (RNA) II (DNA directed) polypeptide Mpolymerase (RNA) II subunit M
02

Biological functions

mRNA synthesisNon-coding RNA synthesisNegative regulation of transcriptional activation (Mediator-dependent repression)Regulation of preinitiation complex (PIC) assembly
03

Disease associations

Other (There is no direct evidence for specific disease involvement; possible indirect roles through global transcriptional regulation, but not established as a classic disease gene)

Beyond the preview

Go deeper on DNA-directed RNA polymerase II subunit M (POLR2M).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase II subunit M (POLR2M).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call